The chart below shows how RXO performed 10 days before and after its earnings report, based on data from the past quarters. Typically, RXO sees a +0.12% change in stock price 10 days leading up to the earnings, and a +0.32% change 10 days following the report. On the earnings day itself, the stock moves by -2.07%. This data can give you a slight idea of what to expect for the next quarter's release.
Positive
Coyote Logistics Integration Progress: Integration of Coyote Logistics is ahead of schedule, with expected call synergies raised to at least $50 million, excluding additional transportation and cross-selling benefits.
Managed Transportation Demand Growth: Sales pipeline for managed transportation has reached nearly $2 billion, indicating strong demand and growth potential.
Last Mile Growth: Last mile stops grew by 15% year over year, showcasing significant operational momentum in this segment.
Director Level Retention Rates: Voluntary turnover of director level and above employees was only about 2%, reflecting strong employee retention and engagement post-acquisition.
Earnings Power Enhancement: Structural improvements are anticipated to enhance earnings power and free cash flow over the long term, positioning the company favorably across market cycles.
Negative
EPS Performance Consistent: Reported EPS of $0.06 was in line with expectations, indicating no growth or improvement compared to previous periods.
Market Challenges Ahead: Despite achieving financial commitments, the overall market remains soft, suggesting potential challenges in future revenue generation.
Integration Challenges: The company is experiencing a significant integration process with Coyote Logistics, which may divert focus and resources from other critical areas of the business.
Director Turnover Insights: Voluntary turnover of director level and above employees was only about 2%, indicating potential issues with employee engagement or satisfaction at lower levels.
Sales Pipeline Uncertainty: The sales pipeline for managed transportation is nearly $2 billion, but this figure does not guarantee conversion into actual revenue, highlighting uncertainty in future performance.
RXO, Inc. (NYSE:RXO) Q4 2024 Earnings Call Transcript
RXO.N
-3.87%